Welcome to Coulter Partners Global (English)

11 April 2023

Top hires for VC & PE portfolio companies Q1-2023

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Diagnostics UK
CEO Oncology biotech Italy
Chief Business Officer Infectious diseases Canada
Chief Development Officer Biologics Netherlands
Chief Business Officer AI monitoring devices France
Chief Research & Development Officer Contract research organization Canada
Country Manager UK Telehealth Norway
SVP Research Ultrasound devices US
VP, Antibody Engineering & Protein Sciences Drug discovery services US
Head of Translational Medicine Cell therapies Switzerland
Global Director, Medical Affairs Plasma derived therapeutics US
Sales Director Digital imaging Germany
Board Director (US) Immuno-oncology France
Partner, Digital Health Investments Life science investor Italy

Newly opened projects include:

Function Focus area Location
CEO AI-enabled precision medicines France
Chief Medical Officer Antibody-drug conjugates (ADCs) Denmark
Chief Business Officer Cell and gene therapies UK
Head of Regulatory & Quality Affairs Imaging biomarkers UK
Global Head of Marketing Natural ingredients and food tech Denmark
VP Business Development Antibody therapeutics US
VP Corporate Development Radiopharmaceuticals China
VP People Cardiac devices France
VP Clinical Affairs Analgesics US
Country Managing Director Veterinary services Belgium
Chair Medical devices US
Board Director (Clinical) Gene therapy UK


A new version of Coulter Partners is available.